German researchers found that a gene mutation can substantially cut heart attack risks by half. Shutting down the angiopoietin-like 4 or ANGPTL4 gene through new medications can cut the number of heart disease patients around the world.
German researchers found that a gene mutation can substantially cut heart attack risks by half. Shutting down the angiopoietin-like 4 or ANGPTL4 gene through new medications can cut the number of heart disease patients around the world.